Breast Cancer Coverage from Every Angle

Marie-Jeanne T.F.D. Vrancken Peeters, MD, PhD, on Surgery After Successful Neoadjuvant Therapy for Early Breast Cancer

Posted: Monday, February 17, 2020

Marie-Jeanne T.F.D. Vrancken Peeters, MD, PhD, of the Netherlands Cancer Institute, discusses the implications for patients of a study that showed clinicians may not yet be able to predict which patients can forgo surgery after successful neoadjuvant therapy.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.